Real-world data analysis of trends in oral anticoagulation use in patients with atrial fibrillation following catheter ablation from a nationwide multicentric registry

IF 5.7 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Heart rhythm Pub Date : 2025-02-21 DOI:10.1016/j.hrthm.2025.02.035

Manasvi Gupta MD , Amit J. Thosani MD, FHRS , Christopher Thorne PhD , Jose Osorio MD, FHRS , Rahul Jain MD, FHRS , Paul C. Zei MD, FHRS , Allyson Varley PhD , Matthew J. Singleton MD, FHRS , Saumil Oza MD, FHRS , Mark Metzl MD, FHRS , Benjamin D'Souza MD, FHRS , Anthony R. Magnano MD, FHRS , Joshua R. Silverstein MD, FHRS

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

来自全国多中心登记的房颤导管消融后口服抗凝用药趋势的真实世界数据分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Heart rhythm 医学-心血管系统

CiteScore

10.50

自引率

5.50%

发文量

1465

审稿时长

24 days

期刊介绍： HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.

期刊最新文献

Lead failure and venous occlusion as potential drivers of extraction difficulty. Corrigendum to "Development and validation of a new disease-specific quality-of-life measure for atrial fibrillation derived from patient perspectives: The Atrial Fibrillation Patient-Reported Outcome Measures (AF-PROMs) Questionnaire," Heart Rhythm, Volume 22, Issue 8, P1922-1934, August 2025. Activation signature valleys are predictive of macroreentrant atrial tachycardia bottlenecks where uniform low voltage and uniform slow conduction reside. Antiarrhythmic Drugs Versus Catheter Ablation for Treatment of Atrial Fibrillation in An Elderly Population: A Retrospective Analysis of Medicare Advantage Enrollees in the United States. Class Ic antiarrhythmic drugs and structural heart disease - time for a randomized controlled study?